Check these vids out: Basketball stars showing off their moves!Only on Flow.TV!!

Merck & Co. and Schering-Plough Corp. fell in New York trading after their cholesterol drug Vytorin failed in a study to prevent complications from heart-valve disease and was linked to a higher rate of cancer.

Check these vids out: Hot models in bikinis that you can win a date with!Only on RipeTV

In the latest disappointment over cholesterol pill Vytorin, a major European study in patients with heart valve disease found the drug didn't prevent worsening of the disease or lower the need for valve ...

News, Culture, Music, Humor.Thousands of Free Videos at VBS.TV

Wall Street turned in a mixed performance Monday as investors watched the price of oil regain ground and decided to cash in some of their gains from the stock market's big rally last week.

New Episodes of Your Favorite TVShows Added Daily. Watch for Free!

TRENTON, N.J.By LINDA A. JOHNSONAssociated PressIn the latest disappointment for cholesterol pill Vytorin, a major European study in patients with heart valve disease found the drug didn't prevent worsening of ...

"Schering-Plough and Merck's cholesterol drug Vytorin doesn't lower the risk of major heart valve problems and need for related surgical procedures, according to a large-scale study.

Wall Street turned in a mixed performance Monday as investors watched the price of oil regain ground and decided to cash in some of their gains from the stock market's big rally last week.

Washington Federal Inc. said net income in the fiscal third quarter was $33.2 million, or 38 cents a share, down from the $34.3 million or 39 cents a share reported a year ago.

Macintosh and iPod sales helped boost Apple Inc.'s fiscal third-quarter earnings 31 percent, beating Wall Street's expectations, but investors pummeled the stock after Apple said profit margins contracted and ...

It was the second dose of bad news on Monday for the drugmaker. Merck shares dropped 6.2 percent in regular trading after the study on Vytorin, sold with Schering-Plough Corp , showed it failed to prevent ...

Pharmaceutical stocks have been rallying of late, buoyed by news of richly priced mergers, including Roche's $44 billion bid for Genentech on July 21 and the $7 billion offer by generic drugmaker Teva ...

Find information on VYTORIN, a high cholesterol medication that inhibits cholesterol production in the liver and blocks cholesterol absorption in the intestine. Learn more about ...

Find information on VYTORIN (ezetimibe/simvastatin), a new medication for high cholesterol that helps in the LDL cholesterol reduction through dual inhibition of the two sources of ...

Vytorin (ezetimibe and simvastatin) lowers bad cholesterol in the blood, and raises good cholesterol. Including Vytorin side effects, interactions and indications.

Comprehensive and trusted information about Vytorin - plus advice on 24,000 other FDA approved drugs and medications from Drugs.com.

... best known as Zocor in the U.S.). The combination preparation is marketed by Merck & Co. / Schering-Plough Pharmaceuticals (joint venture) under the trade names Vytorin and Inegy.

Vytorin, a combination of cholesterol lowering Zetia and the statin Zocor, worked no better to reduce clogged arteries than a high dose of a less-expensive, generically ... ...

Vytorin and Zetia Information. News and Information on Vytorin, Attorneys and Lawyers at LegalView.com

Find Vytorin (Ezetimibe & Simvastatin) medication description and FDA approved drug information including side effects, interactions and patient labeling.

FDA Issues Early Communication about an Ongoing Review of Vytorin ... FOR IMMEDIATE RELEASE January 25, 2008 . Media Inquiries: Susan Cruzan, 301-827-6242

Vytorin is a combination of ezetimibe (Zetia) and simvastatin (Zocor) that is used for treating high levels of cholesterol in the blood.

Find information on VYTORIN, a high cholesterol medication that inhibits cholesterol production in the liver and blocks cholesterol absorption in the intestine. Learn more about ...

Find information on VYTORIN (ezetimibe/simvastatin), a new medication for high cholesterol that helps in the LDL cholesterol reduction through dual inhibition of the two sources of ...

Vytorin (ezetimibe and simvastatin) lowers bad cholesterol in the blood, and raises good cholesterol. Including Vytorin side effects, interactions and indications.

Comprehensive and trusted information about Vytorin - plus advice on 24,000 other FDA approved drugs and medications from Drugs.com.

... best known as Zocor in the U.S.). The combination preparation is marketed by Merck & Co. / Schering-Plough Pharmaceuticals (joint venture) under the trade names Vytorin and Inegy.

Vytorin, a combination of cholesterol lowering Zetia and the statin Zocor, worked no better to reduce clogged arteries than a high dose of a less-expensive, generically ... ...

Vytorin and Zetia Information. News and Information on Vytorin, Attorneys and Lawyers at LegalView.com

Find Vytorin (Ezetimibe & Simvastatin) medication description and FDA approved drug information including side effects, interactions and patient labeling.

FDA Issues Early Communication about an Ongoing Review of Vytorin ... FOR IMMEDIATE RELEASE January 25, 2008 . Media Inquiries: Susan Cruzan, 301-827-6242

Vytorin is a combination of ezetimibe (Zetia) and simvastatin (Zocor) that is used for treating high levels of cholesterol in the blood.